跳至主要内容
临床试验/NCT02988232
NCT02988232已完成4 期

Evaluation of the Efficacy and Safety of Herbal Medicine for Treating Work-related Chronic Low Back Pain: a Multicenter, Randomized, Controlled, Clinical Trial

Gachon University Gil Oriental Medical Hospital1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2016年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
72
试验地点
1
主要终点
Change from Baseline in Numeric Rating Scale of Pain

研究概览

简要总结

The Purpose of this trial is to investigate the efficacy and safety of Sogyeonghwalhyeol-tang(SGHH) on Korean Patients With Work Related Chronic Low Back Pain

详细描述

Investigating the efficacy and safety of Sogyeonghwalhyeol-tang(SGHH) on Korean Patients With Work-related Chronic Low Back Pain

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatients with chief complaint of low back pain in oriental rehabilitation medical center
  • Age 19 - 65
  • Workplace Vulnerable populations(hospital workers, office worker, blue collar workers, transit workers)
  • Patients must include all of the following symptoms:
  • Those who have 4 ~7 cm of VAS pain score;
  • Those who has classified as 'at risk non-complier' or 'pain complaints' by KOSHA questionnaire
  • Ability to have normal communication
  • Ability to give informed consent

排除标准

  • Patients with pain duration of 3 months or less
  • Patients with progressive neurologic deficit or severe neurologic symptoms by SLR test
  • Patients diagnosed with serious pathology(s) which may cause low back pain (e.g. spinal metastasis of tumor(s), acute fracture, etc)
  • Patients with spondylolisthesis or spondylolysis(diagnosed with grade II or higher level)
  • Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
  • Patients with history of spinal surgery
  • Patients with more severe pain than pain caused by low back pain
  • Those who do not (cannot) abide by treatment and follow up due to the mental illness such as behavior disorder, depression, anxiety neurosis etc.
  • Patients with history of Medical Malpractice Case
  • Patients with treatment history of low back pain within 1 month either KM or WM
  • Patients participating in other clinical studies within 3 months
  • Pregnant patients or patients with plans of pregnancy or lactating patients
  • Patients disagree to sign the informed consent form
  • Patients deemed unsuitable for participating the trial by the researchers

研究组 & 干预措施

Treatment(SGHH)

Experimental

Admission to Sogyeonghwalhyeol-tang granule

干预措施: Sogyeonghwalhyeol-tang (Drug)

Placebo

Placebo Comparator

admission to placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Change from Baseline in Numeric Rating Scale of Pain

时间窗: Screening Visit, At baseline, week 2, 4, 6, 8

A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) assesses the patients' current level of pain.

次要结局

  • Change from Baseline in European Quality of life 5 Dimension(Screening Visit, At baseline, week 2, 4, 6, 8)
  • Change from Baseline in 'Roland Morris Disability Questionnaire'(Screening Visit, At baseline, week 2, 4, 6, 8)

研究者

发起方
Gachon University Gil Oriental Medical Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yun-Kyung Song

KMD PhD

Gachon University Gil Oriental Medical Hospital

研究点 (1)

Loading locations...

相似试验